Cerephex

About Cerephex

Cerephex® is a start-up company with an important mission: we are working to become a global leader in noninvasive medical device technologies to help treat and diagnose centralized chronic pain
In June 2011, the Institute of Medicine reported that chronic pain affects as many as 116 million people in the United States alone, and costs the U.S. economy as much as $635 billion dollars every year. Cerephex's business is focused on technologies that address centralization in chronic pain, an emerging paradigm that is advancing knowledge about the fundamental mechanisms of chronic pain
Our current objective is to commercialize our NeuroPoint® product, a point-of-care medical device that is built upon our patented Reduced Impedance Noninvasive Cortical Electrostimulation (RINCE) signal technology platform. Efforts are currently underway to gain FDA approval for NeuroPoint treatment for pain in fibromyalgia
Cerephex's team of top medical device business leaders and medical experts is dedicated to accomplishing the company's objectives and mission, and to creating a business structure to provide high quality clinical solutions to patients and physicians worldwide